Amedeo Smart

Free Medical Literature Service

 

Amedeo

Contraception and Contraceptive Drugs
  Free Subscription

Articles published in
Obstet Gynecol
    October 2026
  1. FANG NZ, Edelman AB, Henderson JT
    Modernizing the Analysis of Migraine With Aura, Oral Contraceptives, and Risk of Stroke: Correction.
    Obstet Gynecol. 2026;148:e274.
    >> Share

    September 2026
  2. HUTCHISON CE, Creinin MD
    Combined Oral Contraception.
    Obstet Gynecol. 2026 Sep 4. doi: 10.1097/AOG.0000000000006424.
    >> Share

    August 2026
  3. FANG NZ, Henderson JT, Edelman AB
    Modernizing the Analysis of Migraine With Aura, Oral Contraceptives, and Risk of Stroke.
    Obstet Gynecol. 2026;148:157-159.
    >> Share

    June 2026
  4. MORI-IWATATE RJ, Santa H, Sagara S, Yoshitomi M, et al
    Ovarian Vein Thrombosis Associated With Oral Contraceptives and Anomalous Renal Venous Drainage.
    Obstet Gynecol. 2026 Jun 11. doi: 10.1097/AOG.0000000000006346.
    >> Share

    May 2026
  5. GIBBS LR, Fox MP, Aparicio HJ, Jick S, et al
    Combined Oral Contraceptives and Stroke Risk in Individuals With Migraine With Aura.
    Obstet Gynecol. 2026 May 7. doi: 10.1097/AOG.0000000000006306.
    >> Share

  6. KNITTEL A, Carmody MD, Falk I, Upputuri S, et al
    Prevalence of Postpartum Permanent Contraception Requests and Fulfillment Among Individuals Experiencing Incarceration and Individuals in the Community.
    Obstet Gynecol. 2026 May 7. doi: 10.1097/AOG.0000000000006309.
    >> Share

    April 2026
  7. KIRKPATRICK L, Harrison EI, Al-Faraj AO, Betstadt SJ, et al
    Epilepsy, Intellectual and Developmental Disabilities, and Contraception in U.S. Medicaid Claims Data.
    Obstet Gynecol. 2026 Apr 9. doi: 10.1097/AOG.0000000000006281.
    >> Share

    March 2026
  8. DESILETS J, Lakabi R, Olsthoorn A, Matelski J, et al
    Effect of Medical Therapies for Endometriosis on Bone Health: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2026 Mar 19. doi: 10.1097/AOG.0000000000006241.
    >> Share

    February 2026
  9. SRIPRASERT I, Hodis HN, Mack WJ, Rosser M, et al
    Elimination of the Black Box Warning on Menopausal Hormone Therapy.
    Obstet Gynecol. 2026 Feb 13. doi: 10.1097/AOG.0000000000006226.
    >> Share

    November 2025

  10. ACOG Committee Statement No. 21: Access to Contraception.
    Obstet Gynecol. 2025;146:e88-e97.
    >> Share

    August 2025
  11. PEARSON A, Shvartsman K, Zeng W, Brown J, et al
    Cost Effectiveness of Salpingectomy Compared With Vasectomy for Permanent Contraception.
    Obstet Gynecol. 2025 Aug 28. doi: 10.1097/AOG.0000000000006042.
    >> Share

  12. KUMASAKA JK, Mandelbaum AD, Edelman AB, Caughey AB, et al
    Cost Effectiveness of Over-the-Counter Availability of Progestin-Only Contraceptive Pills in Abortion-Restrictive and Abortion-Protective Settings.
    Obstet Gynecol. 2025 Aug 21. doi: 10.1097/AOG.0000000000006048.
    >> Share

    June 2025
  13. ARORA KS, Larkin S, Milne J, Carmona Clavijo G, et al
    Goals and Priorities of Community Members Regarding the Federally Mandated Medicaid Sterilization Policy.
    Obstet Gynecol. 2025;146:394-401.
    >> Share

    May 2025
  14. SMEREKA MI, Vivas-Valencia C, Testa A, Byrne JJ, et al
    Expanding Access to Quality Reproductive Health Care After the Dobbs v. Jackson Women's Health Organization Decision.
    Obstet Gynecol. 2025;146:195-201.
    >> Share

  15. KOU L, Huang C, Xiao D, Liao S, et al
    Pharmacologic Interventions for Endometriosis-Related Pain: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2025 May 15. doi: 10.1097/AOG.0000000000005923.
    >> Share

    March 2025
  16. YUK JS, Kim MH, Yoon SH, Han GH, et al
    Association Between Levonorgestrel-Releasing Intrauterine System Exposure Duration and Breast Cancer Incidence.
    Obstet Gynecol. 2025 Mar 13. doi: 10.1097/AOG.0000000000005881.
    >> Share

    February 2025
  17. CARMODY MD, Schultz AL, Berg KA, Bullington BW, et al
    Association Between Comorbidities and Inpatient Postpartum Permanent Contraception Completion.
    Obstet Gynecol. 2025 Feb 6. doi: 10.1097/AOG.0000000000005844.
    >> Share

  18. SOLOMON MD, Zaritsky EF, Warton M, Millman A, et al
    Effects of the Affordable Care Act on Contraception, Pregnancy, and Pregnancy Termination Rates.
    Obstet Gynecol. 2025;145:196-203.
    >> Share

    January 2025
  19. STEENLAND MW, Oviedo D, Bates MA, Zhou A, et al
    Effect of an Intensive Nurse Home Visiting Program on Postpartum Contraceptive Use and Birth Spacing: A Randomized Controlled Trial.
    Obstet Gynecol. 2025;145:3-12.
    >> Share

    December 2024
  20. FRIEDMAN M, Mor L, Shazar R, Paul N, et al
    Treatment of Early Pregnancy Loss With Mifepristone and Misoprostol Compared With Misoprostol Only.
    Obstet Gynecol. 2024 Dec 5. doi: 10.1097/AOG.0000000000005800.
    >> Share


  21. ACOG Committee Statement No. 13: Self-Managed Abortion.
    Obstet Gynecol. 2024;144:e152-e159.
    >> Share

    November 2024
  22. SOLOMON MD, Zaritsky EF, Warton M, Millman A, et al
    Effects of the Affordable Care Act on Contraception, Pregnancy, and Pregnancy Termination Rates.
    Obstet Gynecol. 2024 Nov 1. doi: 10.1097/AOG.0000000000005796.
    >> Share

    September 2024
  23. CASTANO PM
    Postpartum Long-Acting Reversible Contraception: Cost Effectiveness and Patient Desires in a Larger Context.
    Obstet Gynecol. 2024;144:291-293.
    >> Share

    August 2024
  24. WERNICK HJ, Abdel-Rasoul M, Berlan ED, Bonny AE, et al
    Body Mass Index Changes Among Adolescents and Young Adults Using the Etonogestrel Contraceptive Implant.
    Obstet Gynecol. 2024 Aug 30. doi: 10.1097/AOG.0000000000005712.
    >> Share


  25. Rates of Female Sterilization, Vasectomy, and LARC Placement Before and After the Dobbs Decision: A Retrospective Cohort Study [ID 2683404].
    Obstet Gynecol. 2024;144:e46.
    >> Share

    July 2024
  26. BULLARD KA, Ramanadhan S, Caughey AB, Rodriguez MI, et al
    Immediate Postpartum Long-Acting Reversible Contraception for Preventing Severe Maternal Morbidity: A Cost-Effectiveness Analysis.
    Obstet Gynecol. 2024 Jul 25. doi: 10.1097/AOG.0000000000005679.
    >> Share

  27. SIMMONS RG, Carter G, Sanders JN, Turok DK, et al
    Assessing Contraceptive Switching and Discontinuation Over 3 Years in the HER Salt Lake Study.
    Obstet Gynecol. 2024;144:79-88.
    >> Share

    May 2024
  28. SIMMONS RG, Carter G, Sanders JN, Turok DK, et al
    Assessing Contraceptive Switching and Discontinuation Over 3 Years in the HER Salt Lake Study.
    Obstet Gynecol. 2024 May 23. doi: 10.1097/AOG.0000000000005621.
    >> Share

  29. MEYER R, Toussia-Cohen S, Shats M, Segal O, et al
    24-Hour Compared With 12-Hour Mifepristone-Misoprostol Interval for Second-Trimester Abortion: A Randomized Controlled Trial.
    Obstet Gynecol. 2024 May 23. doi: 10.1097/AOG.0000000000005535.
    >> Share

    April 2024
  30. MURPHY E, Pelletier A, Fay K, Bartz D, et al
    National Postpartum Permanent Contraception Practices and Perceived Barriers.
    Obstet Gynecol. 2024 Apr 16. doi: 10.1097/AOG.0000000000005584.
    >> Share

    February 2024

  31. Permanent Contraception: Ethical Issues and Considerations: ACOG Committee Statement No. 8.
    Obstet Gynecol. 2024;143:e31-e39.
    >> Share

    January 2024
  32. BAUERFEIND A, von Stockum S, Boehnke T, Heinemann K, et al
    Venous Thromboembolic Risk of Estradiol Valerate-Dienogest Compared with Ethinyl Estradiol-Levonorgestrel Combined Oral Contraceptives.
    Obstet Gynecol. 2024 Jan 16. doi: 10.1097/AOG.0000000000005509.
    >> Share

  33. KRASHIN JW, Black P, Brannen E, Gard CC, et al
    Geographic Access to Early Pregnancy Loss Management.
    Obstet Gynecol. 2024 Jan 11. doi: 10.1097/AOG.0000000000005505.
    >> Share


  34. ACOG Clinical Consensus No. 3: General Approaches to Medical Management of Menstrual Suppression: Correction.
    Obstet Gynecol. 2024;143:e20.
    >> Share

    December 2023
  35. IZATT A, Greenberg RA, Thorne J, Erdman J, et al
    Ethical and Legal Considerations for Sterilization Refusal in Nulliparous Women.
    Obstet Gynecol. 2023;142:1316-1321.
    >> Share

  36. MITCHELL L, Vellanki B, Tang L, Hunter K, et al
    Contraceptive Provision to Women With Intellectual and Developmental Disabilities Enrolled in Medicaid.
    Obstet Gynecol. 2023;142:1477-1485.
    >> Share

  37. MITCHELL L, Vellanki B, Tang L, Hunter K, et al
    Contraceptive Provision to Women With Intellectual and Developmental Disabilities Enrolled in Medicaid.
    Obstet Gynecol. 2023;142:1477-1485.
    >> Share

    November 2023
  38. RAMANADHAN S, Jensen J
    The Levonorgestrel-Releasing Intrauterine Device as Emergency Contraception: Re-examining the Data.
    Obstet Gynecol. 2023 Nov 21. doi: 10.1097/AOG.0000000000005466.
    >> Share

  39. ALLEN RH, Bartz D
    Opill: The Over-the-Counter Contraceptive Pill.
    Obstet Gynecol. 2023 Nov 9. doi: 10.1097/AOG.0000000000005455.
    >> Share

  40. EBERLE A, Nguyen DB, Smith JP, Mansour FW, et al
    Medical Management of Ovarian Endometriomas: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2023 Nov 9. doi: 10.1097/AOG.0000000000005444.
    >> Share

    October 2023
  41. MITCHELL L, Vellanki B, Tang L, Hunter K, et al
    Contraceptive Provision to Women With Intellectual and Developmental Disabilities Enrolled in Medicaid.
    Obstet Gynecol. 2023 Oct 26. doi: 10.1097/AOG.0000000000005421.
    >> Share

  42. HENKEL A, Miller HE, Zhang J, Lyell DJ, et al
    Prior Cesarean Birth and Risk of Uterine Rupture in Second-Trimester Medication Abortions Using Mifepristone and Misoprostol: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2023 Oct 26. doi: 10.1097/AOG.0000000000005259.
    >> Share


  43. Association of the Cervicovaginal Microbiome With Contraceptive Methods in Hispanic Women Living in Puerto Rico [ID: 1376364]: Correction.
    Obstet Gynecol. 2023;142:996.
    >> Share

    September 2023
  44. BULLINGTON BW, Berg KA, Miller ES, Boozer M, et al
    Association Among Race, Ethnicity, Insurance Type, and Postpartum Permanent Contraception Fulfillment.
    Obstet Gynecol. 2023 Sep 7. doi: 10.1097/AOG.0000000000005328.
    >> Share

    August 2023
  45. DARNEY BG, Biel FM, Oakley J, Coleman-Minahan K, et al
    Contraceptive Method Switching and Long-Acting Reversible Contraception Removal in U.S. Safety Net Clinics, 2016-2021.
    Obstet Gynecol. 2023 Aug 3. doi: 10.1097/AOG.0000000000005277.
    >> Share

  46. FASSETT MJ, Reed SD, Rothman KJ, Pisa F, et al
    Risks of Uterine Perforation and Expulsion Associated With Intrauterine Devices.
    Obstet Gynecol. 2023 Aug 3. doi: 10.1097/AOG.0000000000005299.
    >> Share

    July 2023
  47. MOSESON H, Jayaweera R, Egwuatu I, Grosso B, et al
    Effectiveness of Self-Managed Medication Abortion Between 9 and 16 Weeks of Gestation.
    Obstet Gynecol. 2023 Jul 6. doi: 10.1097/AOG.0000000000005266.
    >> Share


  48. Medicaid and Fulfillment of Postpartum Permanent Contraception Requests: Correction.
    Obstet Gynecol. 2023;142:221-222.
    >> Share


  49. Increasing Access to Intrauterine Devices and Contraceptive Implants: ACOG Committee Statement No. 5: Correction.
    Obstet Gynecol. 2023;142:221.
    >> Share

    May 2023
  50. VALERIE F
    Where Do We Stand With Mifepristone in the United States?: Making Sense of the Madness.
    Obstet Gynecol. 2023 May 24. doi: 10.1097/AOG.0000000000005253.
    >> Share

  51. QURESHEY EJ, Ibarra CJ, Wagner SM, Chen HY, et al
    Effect of a Multimedia Educational Tool on Contraception Use 1 Year Postpartum.
    Obstet Gynecol. 2023 May 4. doi: 10.1097/AOG.0000000000005198.
    >> Share

  52. ARORA KS, Chua A, Miller E, Boozer M, et al
    Medicaid and Fulfillment of Postpartum Permanent Contraception Requests.
    Obstet Gynecol. 2023;141:918-925.
    >> Share

  53. NEBLETT MF 2ND, Stewart EA
    Oral Gonadotropin-Releasing Hormone Antagonists for the Treatment of Uterine Leiomyomas.
    Obstet Gynecol. 2023;141:901-910.
    >> Share

    April 2023
  54. PEARLMAN SHAPIRO M, Myo M, Chen T, Nathan A, et al
    Remote Provision of Medication Abortion and Contraception Through Telemedicine.
    Obstet Gynecol. 2023 Apr 13. doi: 10.1097/AOG.0000000000005205.
    >> Share

  55. CREININ MD, Jensen JT, Chen MJ, Black A, et al
    Combined Oral Contraceptive Adherence and Pregnancy Rates.
    Obstet Gynecol. 2023 Apr 6. doi: 10.1097/AOG.0000000000005155.
    >> Share

  56. CREININ MD, Barnhart KT, Gawron LM, Eisenberg D, et al
    Heavy Menstrual Bleeding Treatment With a Levonorgestrel 52-mg Intrauterine Device.
    Obstet Gynecol. 2023 Apr 6. doi: 10.1097/AOG.0000000000005137.
    >> Share

  57. CHEN BA, Kimble T, Harris LH, Kerns JL, et al
    Levonorgestrel 52-mg Intrauterine Device Efficacy and Safety After More Than 8 Years of Use.
    Obstet Gynecol. 2023 Apr 6. doi: 10.1097/AOG.0000000000005147.
    >> Share

  58. SUZUKI Y, Chen L, Hou JY, St Clair CM, et al
    Systemic Progestins and Progestin-Releasing Intrauterine Device Therapy for Premenopausal Patients With Endometrial Intraepithelial Neoplasia.
    Obstet Gynecol. 2023 Apr 6. doi: 10.1097/AOG.0000000000005124.
    >> Share


  59. Increasing Access to Intrauterine Devices and Contraceptive Implants: ACOG Committee Statement No. 5.
    Obstet Gynecol. 2023;141:866-872.
    >> Share

    March 2023
  60. SCHWARTZ BI, Bear B, Short VL, Kazak AE, et al
    Outcomes of Menstrual Management Use in Transgender and Gender-Diverse Adolescents.
    Obstet Gynecol. 2023 Mar 9. doi: 10.1097/AOG.0000000000005123.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016